We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
10 March 2022
Misleading CE Mark Documentation Certification Issued by Real Companies
Following an LFA verification of a Recipient’s procurement, the QA Team would like to bring to the attention of the procurement community that certain Personal Protective Equipment (PPE) products and medical devices, and related documents, prominentl... -
08 March 2022
Audit of Grants in South Africa
South Africa has made progress in finding and diagnosing HIV patients, and in initiating them on anti-retroviral treatment. -
07 March 2022
Audit of Global Fund Grants in Ukraine
Ukraine has made good progress on HIV, both in terms of linkage to treatment and viral suppression, as well as in significantly reducing infections and deaths. -
04 March 2022
Introducing Project STELLAR
-
23 February 2022
Revised Progress Update and Disbursement Requests (PU/DR) and Performance Ratings
The Global Fund has launched its revised Progress Update and Disbursement Request (PU/DR), a form that allows Principal Recipients to report on progress made on grants funded by the Global Fund. -
18 February 2022
Recalling US FDA Safety Communication on Pulse Oximeter Accuracy and Limitations
The U.S. Food and Drug Administration (FDA) has recently published a safety communication on Pulse Oximeter Accuracy and Limitations. -
11 February 2022
Call for Applications for New Global Fund Independent Evaluation Panel
The Global Fund’s independent evaluation function is being transformed in order to strengthen accountability and learning, based on the results of independent evaluations. The objective is to ensure that evaluations are relevant, timely and of high q... -
02 February 2022
Opportunity for Evaluation of Selected Medicines - Covid-19 Pharmaceutical Products
The Global Fund is inviting manufacturers of COVID-19 pharmaceutical products (namely Molnupiravir 200mg capsules for oral administration) to submit an expression of interest to have their product evaluated by the Expert Review Panel for Pharmaceutic... -
26 January 2022
Global Fund Announces Shunsuke Mabuchi as New Head of Resilient and Sustainable Systems for Health
The Global Fund is pleased to announce that Shunsuke Mabuchi is joining the Global Fund as the new Head of Resilient and Sustainable Systems for Health, starting in March 2022. -
24 January 2022
Embezzlement of Funds From Global Fund Partners